Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 27 Sep 2022 Paromomycin and miltefosine combination as an alternative to treat patients with visceral leishmaniasis in Eastern Africa: A randomized, controlled, multicountry trial Clinical Infectious Diseases
Scientific articles 27 Sep 2022 Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2/3 trial The Lancet Global Health
Scientific articles 26 Sep 2022 Communities’ perception, knowledge, and practices related to human African trypanosomiasis in the Democratic Republic of Congo Diseases
Scientific articles 20 Sep 2022 Our current understanding of Chagas disease and Trypanosoma cruzi infection in the State of Florida – an update on research in this region of the USA Current Tropical Medicine Reports
Scientific articles 4 Sep 2022 A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics Expert Review of Clinical Pharmacology
Scientific articles 18 Aug 2022 The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001–2018 PLOS Neglected Tropical Diseases
Scientific articles 16 Aug 2022 Discovery of substituted di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as novel macrofilaricidal compounds for the treatment of human filarial infections Journal of Medicinal Chemistry
Scientific articles 12 Aug 2022 Need for a standardized translational drug development platform: Lessons learned from the repurposing of drugs for COVID-19 Microorganisms
Scientific articles 4 Aug 2022 A phase-2, randomized, multicenter, placebo-controlled, proof-of-concept trial of oral fexinidazole in adults with chronic indeterminate Chagas disease Clinical Infectious Diseases
Scientific articles 1 Aug 2022 Nuevos enfoques terapéuticos de la infección por T. cruzi/ Enfermedad de Chagas Ciencia e Investigación
Scientific articles 30 Jul 2022 Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma Mycoses
Scientific articles 19 Jul 2022 Definitions matter: Heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis PLOS Global Public Health
Scientific articles 10 Jul 2022 Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2 eBioMedicine
Scientific articles 6 Jul 2022 Chagas disease control-surveillance in the Americas: The multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission Memórias do Instituto Oswaldo Cruz
Scientific articles 4 Jul 2022 Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue Journal of Chromatography B